ArticleMediterranean journal of hematology and infectious diseases2011
Epidemiology of invasive fungal infections in the mediterranean area.
Article in Mediterranean journal of hematology and infectious diseases, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Article
- Global research trends and hotspots on human intestinal fungi and health: a bibliometric visualization study.Frontiers in cellular and infection microbiology · 2024Article
- Biomimetic Nanopillar Silicon Surfaces Rupture Fungal Spores.International journal of molecular sciences · 2023Article
- Growth Performance and Recovery of NosocomialMicroorganisms · 2022Article
- Invasive and Subcutaneous Infections Caused by Filamentous Fungi: Report from a Portuguese Multicentric Surveillance Program.Microorganisms · 2022Article
- Biological exploration of a novel 1,2,4-triazole-indole hybrid molecule as antifungal agent.Journal of enzyme inhibition and medicinal chemistry · 2020Article
- Oral mycobiome identification in atopic dermatitis, leukemia, and HIV patients - a systematic review.Journal of oral microbiology · 2020Review
- Evaluation of Commercially Available Real-Time Polymerase Chain Reaction Assays for the Diagnosis of Invasive Aspergillosis in Patients with Haematological Malignancies.Mycopathologia · 2020Article
- Clinical features in proven and probable invasive fungal disease in children and adolescents at a pediatric referral center: a 5-year experience.World journal of pediatrics : WJP · 2019Article
- Targeting the fungal cell wall: current therapies and implications for development of alternative antifungal agents.Future medicinal chemistry · 2019Review
- Presence of Candida spp. and candidiasis in liver transplant patients.Anais brasileiros de dermatologia · 2018Article
- Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in patients with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.The European journal of health economics : HEPAC : health economics in prevention and care · 2018Article
- Isolation frequency of Candida present on the surfaces of mobile phones and handsx.BMC infectious diseases · 2016Article
- Clinical significance of the isolation of Candida species from hospitalized patients.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2015Article
- Invasive fungal infection caused by geotrichum capitatum in patients with acute lymphoblastic leukemia: a case study and literature review.International journal of clinical and experimental medicine · 2015Article
- Utility of PCR in diagnosis of invasive fungal infections: real-life data from a multicenter study.Journal of clinical microbiology · 2013Article
- Bench-to-bedside review: Rapid molecular diagnostics for bloodstream infection--a new frontier?Critical care (London, England) · 2012Review
- Antibody Peptide based antifungal immunotherapy.Frontiers in microbiology · 2012Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although Candida species remain the relevant cause of IFI, other fungi (especially moulds) have become increasingly prevalent. In particular, Aspergillus species are the leading cause of mould infections but also Glomeromycota (formerly Zygomycetes) and Fusarium species are increasing in frequency, and are associated with high mortality rates. Many of these emerging infections occur as breakthrough infections in patients treated with new antifungal drugs. The causative pathogens, incidence rate and severity are dependent on the underlying condition, as well as on the geographic location of the patient population. France and Italy show the highest incident rates of Fusarium infections in Europe, following the US, where numbers are still increasing. Scedosporium prolificans, which primarily is found in soil in Spain and Australia, is most frequently isolated from blood cultures in a Spanish hospital. Geotrichum capitatum represents another species predominantly found in Europe with especially high rates in Mediterranean countries. The increasing resistance to antifungal drugs especially of these new emerging pathogens is a severe problem for managing these IFIs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.